LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL.
Cancer Cell. 2019 Sep 16;36(3):237-249.e6. doi: 10.1016/j.ccell.2019.07.007. Epub 2019 Aug 22.
Cancer Cell. 2019.
PMID: 31447348
Free PMC article.